Jeevan Scientific Technology Limited (BOM:538837)
66.58
+3.16 (4.98%)
At close: Apr 2, 2026
BOM:538837 Revenue
Jeevan Scientific Technology had revenue of 190.72M INR in the quarter ending December 31, 2025, with 52.48% growth. This brings the company's revenue in the last twelve months to 503.08M, up 5.13% year-over-year. In the fiscal year ending March 31, 2025, Jeevan Scientific Technology had annual revenue of 468.44M with 18.14% growth.
Revenue (ttm)
503.08M
Revenue Growth
+5.13%
P/S Ratio
2.00
Revenue / Employee
1.91M
Employees
263
Market Cap
1.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 468.44M | 71.93M | 18.14% |
| Mar 31, 2024 | 396.51M | 34.73M | 9.60% |
| Mar 31, 2023 | 361.78M | -323.55M | -47.21% |
| Mar 31, 2022 | 685.33M | 210.50M | 44.33% |
| Mar 31, 2021 | 474.83M | 225.84M | 90.70% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 1, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lactose (India) | 1.45B |
| James Warren Tea | 1.16B |
| Evexia Lifecare | 1.13B |
| Resonance Specialties | 899.72M |
| RSD Finance | 737.54M |
| Gautam Exim | 324.38M |
| Pharmaids Pharmaceuticals | 255.33M |
| Saumya Consultants | 167.92M |